Together, this work further establishes SETD2 as a tubulin methyltransferase and provides a molecular basis for changes in tubulin and histone methylation derived from ccRCC mutations in SETD2 because of SRI-domain regulation. Here, SETD2 is linked to nonpapillary renal cell carcinoma.